BMJ Open is committed to open peer review. As part

1 downloads 0 Views 2MB Size Report
Oct 13, 2017 - Appendectomy OR Appendices OR “Appendix Epiploica” OR “ ...... randomized controlled multicenter trial comparing antibiotic therapy with.
BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or payper-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected]

BMJ Open

Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol

Journal:

BMJ Open

Fo

Manuscript ID Article Type:

bmjopen-2017-020101 Protocol

rp

Date Submitted by the Author:

Complete List of Authors:

13-Oct-2017

Keywords:

ev

rr

ee

Danwang, Celestin; Faculty of Medecine and Biomedical Sciences, Surgery and specialities Mazou, Temgoua Ngou ; Faculty of Medecine and Biomedical Sciences, Internal medicine and specialities Tochie, Joel Noutakdie; Universite de Yaounde I Faculte de Medecine et des Sciences Biomedicales, Nzalie, Rolf ; Ngong District Hospital, North Region, Cameroon Bigna, Jean Joel; Centre Pasteur of Cameroon, Department of Epidemiology and Public Health surgical site infection, appendectomy, prevalence, Incidence

iew ly

on For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 1 of 16

Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol Celestin Danwang1*, Mazou N.Temgoua2, Joel NoutakdieTochie1, Rolf Nyah Tuku Nzalie3, Jean Joel Bigna4, 5

1. Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Fo

2. Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

rp

3. Ngong District Hospital, North Region, Cameroon.

ee

4. Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaoundé, Cameroon.

rr

5. School of Public Health, Faculty of Medicine, University of Paris Sud XI, Le KremlinBicêtre, France.

iew

ev

E-mail addresses: CD: [email protected]; MNT: [email protected]; JNT: [email protected]; RNN:[email protected]; JJB: [email protected]. *Corresponding author: Dr.Celestin Danwang, MD Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon. E-mail: [email protected]. Phone number: +237696783172

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

1 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Abstract Introduction Acute appendicitis is a surgical emergency and the most frequent etiology of surgical acute abdominal pain in developed countries. Its currently recognized treatment is appendectomy. It is estimated that, 300 000 people undergo appendectomy each year in the United States (US). Like all surgical procedures, appendectomy can be associated with many complications like cecal fistulas, persistent ileus, pelvic or abdominal abscess and surgical site infection (SSI).

Fo

SSI is associated with a prolonged postoperative morbidity and hospitalization stay, a

rp

substantial additional healthcare cost, making this complication a serious concern for all surgical teams.

ee

Despite the increasing number of appendectomies done around the world and the problems

rr

caused by SSI after appendectomy, there is still scarcity of data concerning the global

ev

epidemiology of SSI after appendectomy. The current review aims at providing a summary of the published data on epidemiology of SSI after appendectomy. Methods and design

iew on

We will include cross-sectional studies, randomized controlled trials, case–control and cohort studies. Electronic databases including EMBASE, MEDLINE and ISI Web of Science

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 16

(Science Citation Index), will be searched for relevant abstracts of studies published between January 1, 2000, and December 30, 2017, without language restriction. The review will be reported according to the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. After screening of abstracts, study selection, data extraction and assessment of risk of bias, we shall assess the studies individually for clinical and statistical heterogeneity. Appropriate meta-analytic techniques will then be used to pool studies judged to be clinically

2 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 3 of 16

homogenous. Visual inspection of Funnel-plots and Egger’s test will be used to detect publication bias. Results will be presented by country and continent.

Ethics and dissemination Since primary data are not collected in this study, ethical approval is not required. This review

Fo

is expected to provide relevant data to help in quantifying the global burden of SSI after

rp

appendectomy. The final report will be published in a peer-reviewed journal.

rr

ee Systematic review registration: International Prospective Register for Systematic Reviews (PROSPERO) number: CRD42017075257.

ev

Keywords: surgical site infection; appendectomy; prevalence, incidence.

iew

Strengths and limitations of the study

ly



on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

To the best of our knowledge, this will be the first systematic review summarizing data concerning SSI after appendectomy in the world.



This review will be conducted with strong and robust methodological processes and statistical analyses to help in providing the highest level of evidence that will help to acquire a better evidence-based decision making on the topic.

3 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Introduction Defined as an acute inflammation of the appendix, acute appendicitis is the most frequent etiology of surgical acute abdominal pain in developed countries(1). Its currently recognized treatment is appendectomy (2, 3). In the USA, the annual number of people undergoing

Fo

appendectomy in acute care hospital is estimated at 300 000(4-6).

rp

Appendectomy can be performed through a laparoscopic or an open surgery technique, with laparoscopy being the most recommended method (7-10). This is because it is associated with

ee

reduced postoperative pain, a short length of hospital stay with a subsequent earlier return to day-to-day activities, reduced postoperative ileus, and better cosmetic results(7-10). Within

rr

the last five decades, the mortality associated with acute appendicitis has significantly

ev

dropped from 26% to less than 1% (11, 12).

iew

Like all surgical procedures, appendectomy can be associated with several postoperative complications like persistent ileus, cecal fistula, pelvic or abdominal abscess and surgical site

on

infection (SSI)(13). SSI is associated with a prolonged post operative morbidity, a substantial additional healthcare cost, making this complication a concern for all surgical teams. Some

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 16

studies done in Brazil, Sweden, China and US report SSI prevalence rates of 7.2%, 5.9%, 6.2% and 2.9% respectively after appendectomy(14). Apart from these isolated studies, there is still scarcity of data concerning the global epidemiology of SSI after appendectomy, despite the increasing number of appendectomies done in the world. The current systematic review and meta-analysis aims at summarizing the available data concerning prevalence and incidence of SSI after appendectomy.

4 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 5 of 16

Review questions 1. What is the global prevalence of surgical site infection after appendectomy? 2. What is the global incidence of surgical site infection after appendectomy?

Objectives This systematic review and meta-analysis aims to:

Fo

1. Determine the global prevalence of SSI after appendectomy; 2. Determine the global incidence of SSI after appendectomy.

Methods and design

ee

rp

This systematic review and meta-analysis will be reported in conformity with the Meta-

rr

analysis of Observational Studies in Epidemiology (MOOSE) guidelines(15). For the present

ev

protocol, the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) for Protocol was used for the reporting(16). An additional file shows the PRISMA for protocol checklist [see Additional File 1].

iew

Criteria for considering studies for the review

ly

Types of studies

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

We will include cross-sectional studies, randomized controlled trials, case–control and cohort studies. Only studies reporting the used of CDC (Center for Disease Control) terminology and diagnostic criteria for SSI will be considered (17, 18). Letters, reviews, commentaries and editorials will be excluded. Types of participants We will include all participants regardless of their country, age and ethnicity.

5 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Types of outcomes We will consider studies reporting the following outcomes with enough data to compute these estimates: •

Prevalence of SSI after appendectomy;



Incidence of SSI after appendectomy.

Studies, in which relevant data on SSI after appendectomy is impossible to extract, will be excluded.

Other criteria

rp

Fo

 All published data between January 1, 2000 and Dcember 30, 2017 will be considered.

ee

 No language restriction will be applied.

rr

 For duplicates of studies published in more than one report, the one reporting the largest sample size will be considered.

ev

 Studies with inaccessible full text either online or from the corresponding author will be excluded.

iew

Search strategy for identifying relevant studies

The search strategy will be conducted in two stages:

ly

Bibliographic database searches

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 16

Relevant articles published on SSI after appendectomy will be identified by searching Excerpta Medica Database (EMBASE), MEDLINE through PubMed, and ISI Web of Science (Science Citation Index), between January 1, 2000 and December 30, 2017, without any language restriction. Text words and medical subject heading terms related to SSI and appendicitis will be used (Table 1). When necessary, contact with authors for more information will be made. 6 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 7 of 16

Searching for other sources We will scan the references of all relevant articles for additional data sources missed during our search, and their full-texts will be retrieved. References of pertinent reviews will also be scanned. Selection of studies for inclusion in the review Two reviewers (CD and MNT) will independently evaluate the studies obtained from the

Fo

searches, using an assessment form to ensure that the selection criteria are reliably applied. These reviewers will screen the titles and abstracts of papers obtained, after which the full

rp

texts of potentially eligible papers will be retrieved by at least one reviewer. The two

ee

reviewers will independently review the full text of each potentially eligible study, compare their results and resolved any discrepancy by the arbitration of a third reviewer (JNT).

rr

Assessment of methodological quality and reporting of data

ev

Methodological quality and risk of bias of included studies will be assessed using an adapted

iew

version of the Risk of Bias Tool for Prevalence Studies developed by Hoy et al(19). An additional file shows the tool in detail [see Additional file 2]. Since there is no validated study

on

that provides a cut-off score for rating quality of studies; a priori, we will arbitrarily consider 0-4, 5-7, and 8-10 as high, moderate, and low risk of bias respectively.

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

Data extraction and management All references identified after implementation of the searched strategy will be imported inside the Endnote software. All records obtained from various databases will be combined in a single Endnote library and the duplicates will be noted and removed. A data extraction form will thereafter be used to collect information on the last name of the first author, year of publication, continent, country, study design, study area (rural versus urban), health care 7 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

facility (primary or other center), sample size, mean or median age, gender, specific characteristics of the study population, the surgical method (open surgery or laparoscopy), prevalence and incidence of SSI after appendectomy in the study population. For multinational studies, the prevalence and incidence will be reported for the individual countries. Where it is impossible to disaggregate data of multinational studies by country, the study will be presented as one and the countries in which the study was done will be reported. Data synthesis and analysis

Fo

After data collection, a meta-analysis will be conducted. Unadjusted prevalence and

rp

incidence, and standard errors for the study-specific estimates will be recalculated based on

ee

the information of crude numerators and denominators provided by individual studies. To keep the effect of studies with extremely small or extremely large prevalence estimates on the

rr

overall estimate to a minimum, the variance of the study-specific prevalence/incidence will be

ev

stabilized with the Freeman-Tukey double arc-sine transformation(20), before poling the data

iew

using a random effects meta-analysis model. Heterogeneity will be assessed using the χ2 test on Cochrane’s Q statistic, and quantified by calculating I2(21). Values of 25%, 50% and 75% for I2will represent respectively, low, medium and high heterogeneity. We will assess the

on

presence of publication bias using funnel plots inspection and Egger’s test (22). Where substantial heterogeneity will be detected, meta-regression and subgroup analyses will be

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 16

performed to investigate the possible sources of heterogeneity using the aforementioned variables and the study quality. In case of substantial clinical heterogeneity, a narrative summary of our findings will be done. The inter-rater agreement for study inclusion between investigators will be assessed using Cohen’s κ coefficient(23). Data analyses will be done usingthe ‘meta’ package of the statistical software R (version 3.2.2 [2014-08-14], The R Foundation for statistical computing, Vienna, Austria).

8 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 9 of 16

Presentation and reporting of results The study selection process will be summarized using a flow diagram. Quantitative data will be presented in tables of individual studies and in summary tables, and forest plots where appropriate. The quality scores and risk of bias for each eligible study will be reported accordingly. This may be tabulated and accompanied by narrative summaries.

Fo

Potential amendments

rp

Any amendment in the review process will be reported transparently.

Conclusion

rr

ee

SSI after appendectomy is one of the complications of the surgical treatment of appendicitis.

ev

This systematic review aims at providing data of high level of evidence concerning epidemiology of SSI after appendectomy. We hope this review will help to sensitize surgeons

iew

to implement effective strategies to prevent SSI in order to scale-down the burden SSI after appendectomy.

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

Review status: Preliminary searches. Abbreviations MOOSE: Meta-analysis of Observational Studies in Epidemiology.

9 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

PRISMA: Preferred Reporting Items for Systematic Review and Meta-Analysis. SSI: Surgical Site Infection. Declarations Acknowledgments None to declare Competing interests

Fo

The authors declare that they have no competing interests. Funding

ee

rp

This review received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

ev

Authors’ Contributions

rr

CD had the idea. CD designed and conceived the protocol and drafted the manuscript. MNT,

iew

JNT, RNN and JJB participated in the critical revision of the manuscript for methodology and intellectual content. JJB is the guarantor of the review. All authors approved the final version of this manuscript.

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 16

References 1. Birnbaum BA, Wilson SR. Appendicitis at the millennium. Radiology 2000;215:33748. 2. Ansaloni L, Catena F, Coccolini F, Ercolani G, Gazzotti F, Pasqualini E, et al. Surgery versus conservative antibiotic treatment in acute appendicitis: a systematic review and metaanalysis of randomized controlled trials. Dig Surg 2011;28:210-21.

10 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 11 of 16

3. Paajanen H, Gronroos JM, Rautio T, Nordstrom P, Aarnio M, Rantanen T, et al. A prospective randomized controlled multicenter trial comparing antibiotic therapy with appendectomy in the treatment of uncomplicated acute appendicitis (APPAC trial). BMC Surg 2013;13:3. 4. Garcell HG, Arias AV, Sandoval CA, Garcia EG, Gamboa ME, Sado AB, et al. Incidence and Etiology of Surgical Site Infections in Appendectomies: A 3-Year Prospective Study. Oman Med J 2017;32:31-5. 5. Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol 1990 ;132:910-25. 6. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009;37:387-97. 7. Antal A. [Changes in epidemiology, etiology, diagnostics, and therapy of acute appendicitis]. Orv Hetil 2009;150:443-6. 8. Minutolo V, Licciardello A, Di Stefano B, Arena M, Arena G, Antonacci V. Outcomes and cost analysis of laparoscopic versus open appendectomy for treatment of acute appendicitis: 4-years experience in a district hospital. BMC Surg 2014 ;14:14. 9. Wei B, Qi CL, Chen TF, Zheng ZH, Huang JL, Hu BG, et al. Laparoscopic versus open appendectomy for acute appendicitis: a metaanalysis. Surg Endosc 2011;25:1199-208. 10. Long KH, Bannon MP, Zietlow SP, Helgeson ER, Harmsen WS, Smith CD, et al. A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery 2001;129:390-400. 11. Margenthaler JA, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson WG, et al. Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg 2003;238:59-66. 12. Berry J, Jr., Malt RA. Appendicitis near its centenary. Ann Surg 1984;200:567-75. 13. Leung TT, Dixon E, Gill M, Mador BD, Moulton KM, Kaplan GG, et al. Bowel obstruction following appendectomy: what is the true incidence? Ann Surg 2009;250:51-3. 14. Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kubler A, Viet-Hung N, et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol 2013;34:597-604. 15. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-12. 16. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1. 17. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. 18. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8. 19. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012;65:934-9. 20. Miller JJ. The Inverse of the Freeman – Tukey Double Arcsine Transformation. The American Statistician 1978;32:138.

iew

ev

rr

ee

rp

Fo

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

11 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

21. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006;11:193-206. 22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. 23. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22:276-82.

iew

ev

rr

ee

rp

Fo Table 1: Search strategy for PubMed from January 1st, 2000 to Decembre 30th, 2017

Search

Search terms

#1

Appendectomy OR Appendices OR “Appendix Epiploica” OR “Omental Appendix” OR Appendicitis

ly

#2

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 16

“Surgical site infection” OR “Surgical wound infection” OR “Surgical wound infections” OR “Surgical site infections” OR “Postoperative Wound Infections” OR “Postoperative Wound Infection”

#3

#1 AND #2

12 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 13 of 16 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47

BMJ Open

1

PRISMAPRISMA-P 2015 Checklist This checklist has been adapted for use with systematic review protocol submissions to BioMed Central journalsfrom Table 3 in Moher D et al:: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews2015 4:1

Fo

rp

An Editorial from the Editors-in-Chief of Systematic Reviews details why this checklist was adapted -Moher D, Stewart L & Shekelle P:: Implementing PRISMA-P: recommendations for prospective authors. Systematic Reviews20165 5:15

Section/topic

#

Checklist item

ADMINISTRATIVE INFORMATION Title

ee

Information reported Page

rr

Yes

ev

iew

No

number(s)

1

Identification

1a

Identify the report as a protocol of a systematic review

Update

1b

If the protocol is for an update of a previous systematic review, identify as such

2

If registered, provide the name of the registry (e.g., PROSPERO) and registration number in the Abstract

Contact

3a

Provide name, institutional affiliation, and e-mail address of all protocol authors; provide physical mailing address of corresponding author

1

Contributions

3b

Describe contributions of protocol authors and identify the guarantor of the review

10

4

If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; otherwise, state plan for documenting important protocol amendments

Sources

5a

Indicate sources of financial or other support for the review

10

Sponsor

5b

Provide name for the review funder and/or sponsor

10

5c

Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol

Registration

Authors

Amendments

on

ly

3

Support

Role of sponsor/funder

INTRODUCTION

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

10

BMJ Open 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47

Page 14 of 16

2

Information reported Page Section/topic Rationale

Objectives

# 6

7

METHODS

Checklist item

Yes

Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO)

rp

ee

number(s) 4

Describe the rationale for the review in the context of what is already known

Fo

No

5

8

Specify the study characteristics (e.g., PICO, study design, setting, time frame) and report characteristics (e.g., years considered, language, publication status) to be used as criteria for eligibility for the review

5_6

Eligibility criteria Information sources

9

Describe all intended information sources (e.g., electronic databases, contact with study authors, trial registers, or other grey literature sources) with planned dates of coverage

6-7

Search strategy

10

Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated

6-7

Data management

11a

Describe the mechanism(s) that will be used to manage records and data throughout the review

7

Selection process

11b

State the process that will be used for selecting studies (e.g., two independent reviewers) through each phase of the review (i.e., screening, eligibility, and inclusion in meta-analysis)

7

Data collection process

11c

Describe planned method of extracting data from reports (e.g., piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators

7

Data items

12

List and define all variables for which data will be sought (e.g., PICO items, funding sources), any pre-planned data assumptions and simplifications

5-6

Outcomes and prioritization

13

List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale

6

Risk of bias in individual studies

Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis

7

14

15a

Describe criteria under which study data will be quantitatively synthesized

8

15b

If data are appropriate for quantitative synthesis, describe planned summary measures, methods of

8-9

STUDY RECORDS

rr

ev

iew

on

ly

DATA Synthesis

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 15 of 16 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47

BMJ Open

3

Information reported Page Section/topic

#

Checklist item

Yes

No

number(s)

handling data, and methods of combining data from studies, including any planned exploration of 2 consistency (e.g., I , Kendall’s tau)

Fo

15c

Describe any proposed additional analyses (e.g., sensitivity or subgroup analyses, metaregression)

8-9

15d

If quantitative synthesis is not appropriate, describe the type of summary planned

9

Meta-bias(es)

16

Specify any planned assessment of meta-bias(es) (e.g., publication bias across studies, selective reporting within studies)

8

Confidence in cumulative evidence

17

Describe how the strength of the body of evidence will be assessed (e.g., GRADE)

rp

ee

rr

8

ev

iew

on

ly

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Additional File 2. Risk of bias assessment tool for prevalence, incidence and aetiologies outcomes Risk of Bias Item

Answer: Yes (Low Risk) or No (High risk)

External Validity 1. Was the study target population a close representation of the national population in relation to relevant variables? 2. Was the sampling frame a true or close representation of the target population? 3. Was some form of random selection used to select the sample, OR, was a census undertaken? 4. Was the likelihood of non-participation bias minimal?

Fo

Internal Validity 5. Were data collected directly from the subjects (as opposed to medical records)? 6. Were acceptable case definition of condition used? 7. Was a reliable and accepted diagnosis method utilized? 8. Was the same mode of data collection used for all subjects? 9. Was the length of the shortest prevalence period for the parameter of interest appropriate? 10. Were the numerator(s) and denominator(s) for the calculation of the prevalence appropriate? 11. Summary item on the overall risk of study bias

iew

ev

rr

ee

rp

LOW RISK OF BIAS: 8 or more “yes” answers. Further research is very unlikely to change our confidence in the estimate. MODERATE RISK OF BIAS: 6 to 7 “yes” answers. Further research is likely to have an important impact on our confidence in the estimate and may change the estimate.

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 16 of 16

HIGH RISK OF BIAS: 5 or fewer “yes” answers. Further research is very likely to have an important impact on our confidence in the estimate and is likely to change the estimate.

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol

Journal:

BMJ Open

Fo

Manuscript ID Article Type:

bmjopen-2017-020101.R1 Protocol

rp

Date Submitted by the Author:

Complete List of Authors:

28-Feb-2018

Primary Subject Heading:

Keywords:

iew

Secondary Subject Heading:

Surgery

ev

rr

ee

Danwang, Celestin; Faculty of Medecine and Biomedical Sciences, Surgery and specialities Mazou, Temgoua Ngou ; Faculty of Medecine and Biomedical Sciences, Internal medicine and specialities Tochie, Joel Noutakdie; Universite de Yaounde I Faculte de Medecine et des Sciences Biomedicales, Nzalie, Rolf ; Ngong District Hospital, North Region, Cameroon Bigna, Jean Joel; Centre Pasteur of Cameroon, Department of Epidemiology and Public Health

Epidemiology, Gastroenterology and hepatology surgical site infection, appendectomy, prevalence, Incidence

ly

on For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 1 of 18

Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol Celestin Danwang1*, Mazou N. Temgoua2, Joel NoutakdieTochie1, Rolf Nyah Tuku Nzalie3, Jean Joel Bigna4, 5

1. Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Fo

2. Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

rp

3. Ngong District Hospital, North Region, Cameroon.

ee

4. Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaoundé, Cameroon.

rr

5. School of Public Health, Faculty of Medicine, University of Paris Sud XI, Le KremlinBicêtre, France.

iew

ev

E-mail addresses: CD: [email protected]; MNT: [email protected]; JNT: [email protected]; RNN: [email protected]; JJB: [email protected]. *Corresponding author: Dr. Celestin Danwang, MD Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon. E-mail : [email protected]. Phone number: +237696783172

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

1 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Abstract Introduction Acute appendicitis is a surgical emergency and the most frequent etiology of surgical acute abdominal pain in developed countries. Its currently recognized treatment is appendectomy. Like all surgical procedures, appendectomy can be associated with many complications among which surgical site infections (SSI). Despite the increasing number of appendectomies done around the world and the problems

Fo

caused by SSI after appendectomy, there is still scarcity of data concerning the global

rp

epidemiology of SSI after appendectomy. The current review aims at providing a summary of the published data on epidemiology of SSI after appendectomy.

rr

Methods and design

ee

We will include cross-sectional studies, randomized controlled trials, case–control and cohort

ev

studies. Electronic databases including EMBASE, MEDLINE and ISI Web of Science

iew

(Science Citation Index), will be searched for relevant abstracts of studies published between January 1, 2000, and December 30, 2017, without language restriction. The review will be

on

reported according to the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) guidelines. After screening of abstracts, study selection, data extraction

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 18

and assessment of risk of bias, we shall assess the studies individually for clinical and statistical heterogeneity. Appropriate meta-analytic techniques will then be used to pool studies judged to be clinically homogenous. Visual inspection of Funnel-plots and Egger’s test will be used to detect publication bias. Results will be presented by country and continent.

2 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 3 of 18

Ethics and dissemination Since primary data are not collected in this study, ethical approval is not required. This review is expected to provide relevant data to help in quantifying the global burden of SSI after appendectomy. The final report will be published in a peer-reviewed journal.

Systematic review registration: International Prospective Register for Systematic Reviews

Fo

(PROSPERO) number: CRD42017075257.

rp

Keywords: surgical site infection; appendectomy; prevalence, incidence.

iew

ev

rr

ee ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

3 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Introduction Defined as an acute inflammation of the appendix, acute appendicitis is the most frequent etiology of surgical acute abdominal pain in developed countries (1). Its currently recognized treatment is appendectomy (2, 3). In the USA, the annual number of people undergoing appendectomy in acute care hospital is estimated at 300 000 (4-6).

Fo

Appendectomy can be performed through a laparoscopic or an open surgery technique, with laparoscopy being the most recommended method (7-10). This is because it is associated with

rp

reduced postoperative pain, a short length of hospital stay with a subsequent earlier return to

ee

day-to-day activities, reduced postoperative ileus, and better cosmetic results (7-10). Within the last five decades, the mortality associated with acute appendicitis has significantly

rr

dropped from 26% to less than 1% (11, 12).

ev

Like all surgical procedures, appendectomy can be associated with several postoperative

iew

complications like persistent ileus, cecal fistula, pelvic or abdominal abscess and, surgical site infection (SSI) (13). SSI is associated with a prolonged postoperative morbidity, a substantial additional healthcare cost, making this complication a concern for all surgical teams (14, 15).

on

Some studies done in Brazil, Sweden, China and US report SSI prevalence rates of 7.2%,

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 18

5.9%, 6.2% and 2.9% respectively after appendectomy (16). Moreover, a recent systematic review on surgical site infections after appendectomy performed in low and middle human development-index countries (LMHDICs) (17) found a high rate of SSI in LMHDICs compared to data of isolated studies done in high Human Development-Index Countries (HHDICs). The aforementioned systematic review differs from the review we plan to do by the fact that, our systematic review will integrate data from developed and developing

4 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 5 of 18

countries and, will thus enable to have a global estimation of the burden posed by SSI after appendectomy. In addition, our systematic review will be associated with meta-analysis. Faced with this gap in the contemporary literature, it is evident that there is still scarcity of data regarding the global epidemiology of SSI after appendectomy, despite the increasing number of appendectomies done in the world. The current systematic review and metaanalysis aims at summarizing the available data concerning prevalence and incidence of SSI after appendectomy.

Review questions

ee

rp

Fo 1. What is the global prevalence of surgical site infection after appendectomy?

rr

2. What is the global incidence of surgical site infection after appendectomy?

iew

Objectives

ev

This systematic review and meta-analysis aims to:

1. Determine the global prevalence of SSI after appendectomy;

on

2. Determine the global incidence of SSI after appendectomy.

Methods and design

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

This systematic review and meta-analysis will be reported in conformity with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines (18). For the present protocol, the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA-P) for Protocol was used for the reporting (19). An additional file shows the PRISMA-P for protocol checklist [see Additional File 1].

5 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Criteria for considering studies for the review Types of participants We will include all participants regardless of their country, age and ethnicity. Types of studies We will include cross-sectional studies, randomized controlled trials, case–control and cohort studies. Only studies reporting the used of CDC (Center for Disease Control) terminology and

Fo

diagnostic criteria for SSI will be considered (20, 21).

rp

Letters, reviews, commentaries and editorials will be excluded. Types of outcomes

ee

We will consider studies reporting the following outcomes with enough data to compute these

rr

estimates: •

Prevalence of SSI after appendectomy;



Incidence of SSI after appendectomy.

iew

ev

Studies, in which relevant data on SSI after appendectomy is impossible to extract, will be excluded.

ly

Other criteria

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 18

 All published data between January 1, 2000 and December 30, 2017 will be considered.  No language restriction will be applied.  For duplicates of studies published in more than one report, the one reporting the largest sample size will be considered.  Studies with inaccessible full text either online or from the corresponding author will be excluded.

6 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 7 of 18

Search strategy for identifying relevant studies The search strategy will be conducted in two stages: Bibliographic database searches Relevant articles published on SSI after appendectomy will be identified by searching Excerpta Medica Database (EMBASE), MEDLINE through PubMed and, ISI Web of Science (Science Citation Index), between January 1, 2000 and December 30, 2017, without any

Fo

language restriction. Text words and, medical subject heading terms related to SSI and, appendicitis will be used (Table 1). When necessary, contact with authors for more

rp

information will be made.

ee

Searching for other sources

rr

We will scan the references of all relevant articles for additional data sources missed during our search and, their full-texts will be retrieved. References of pertinent reviews will also be scanned.

iew

ev

Selection of studies for inclusion in the review

Two reviewers (CD and MNT) will independently evaluate the studies obtained from the

on

searches, using an assessment form to ensure that the selection criteria are reliably applied.

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

These reviewers will screen the titles and, abstracts of papers obtained, after which the full texts of potentially eligible papers will be retrieved by at least one reviewer. The two reviewers will independently review the full text of each potentially eligible study, compare their results and, resolved any discrepancy by the arbitration of a third reviewer (JNT). Assessment of methodological quality and reporting of data Methodological quality and risk of bias of included studies will be assessed using an adapted version of the Risk of Bias Tool for Prevalence Studies developed by Hoy et al (22). This tool 7 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

will be adapted to the Cochrane’s bias assessment tool for the randomized studies (23). An additional file shows the tool in detail [see Additional file 2]. Since there is no validated study that provides a cut-off score for rating quality of studies; a priori, we will arbitrarily consider 0-4, 5-7, and 8-10 as high, moderate, and low risk of bias respectively. Data extraction and management All references identified after implementation of the searched strategy will be imported inside

Fo

the Endnote software. All records obtained from various databases will be combined in a single Endnote library and, the duplicates will be noted and, removed. A data extraction form

rp

will thereafter be used to collect information on the last name of the first author, year of

ee

publication, continent, country, study design, study area (rural versus urban), age groups (children or adults), high-risk patients for SSI (patients with diabetes mellitus, HIV/AIDS),

rr

clinical type of appendicitis (catarrhal, perforated, suppurated, gangrenous), medical

ev

interventions before appendectomy (antibiotherapy, analgesics) health care facility (primary

iew

or other center), sample size, mean or median age, gender, specific characteristics of the study population, the surgical method (open surgery or laparoscopy), prevalence and, incidence of SSI after appendectomy in the study population. For multinational studies, the prevalence and,

on

incidence will be reported for the individual countries. Where it is impossible to disaggregate data of multinational studies by country, the study will be presented as one and, the countries in which the study was done will be reported.

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 18

Data synthesis and analysis After data collection, a meta-analysis will be conducted. Unadjusted prevalence and, incidence, and standard errors for the study-specific estimates will be recalculated based on the information of crude numerators and, denominators provided by individual studies. To keep the effect of studies with extremely small or extremely large prevalence estimates on the 8 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 9 of 18

overall estimate to a minimum, the variance of the study-specific prevalence/incidence will be stabilized with the Freeman-Tukey double arc-sine transformation (24), before poling the data using a random effects meta-analysis model. Heterogeneity will be assessed using the χ2 test on Cochrane’s Q statistic and, quantified by calculating I2 (25). Values of 25%, 50% and, 75% for I2will represent respectively, low, medium and, high heterogeneity. We will assess the presence of publication bias using funnel plots inspection and, Egger’s test (26). Where substantial heterogeneity will be detected, meta-regression and, subgroup analyses will be

Fo

performed to investigate the possible sources of heterogeneity using the aforementioned

rp

variables and, the study quality. In case of substantial clinical heterogeneity, a narrative summary of our findings will be done. The inter-rater agreement for study inclusion between

ee

investigators will be assessed using Cohen’s κ coefficient (27). Data analyses will be done using the ‘meta’ package of the statistical software R (version 3.2.2 [2014-08-14], The R

rr

Foundation for statistical computing, Vienna, Austria). This systematic review protocol is

ev

registered under the review number: CRD42017070480 in the International Prospective

iew

Register of Systematic Reviews (PROSPERO) (28). Presentation and reporting of results

on

The study selection process will be summarized using a flow diagram. Quantitative data will be presented in tables of individual studies and, in summary tables and, forest plots where

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

appropriate. The quality scores and, risk of bias for each eligible study will be reported accordingly. This may be tabulated and, accompanied by narrative summaries. Patient and Public Involvement In this study, data will not be collected directly from patients, but in published studies available in main databases.

9 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Potential amendments Any amendment in the review process will be reported transparently.

Conclusion SSI after appendectomy is one of the complications of the surgical treatment of appendicitis. This systematic review aims at providing data of high level of evidence concerning epidemiology of SSI after appendectomy. We hope this review will help to sensitize surgeons

Fo

to implement effective strategies to prevent SSI in order to scale-down the burden SSI after appendectomy.

Strengths and limitations of the study

iew



ev

rr

ee

rp

To the best of our knowledge, this will be the first global systematic review summarizing data concerning SSI after appendectomy.



This review will be conducted with strong and, robust methodological processes and,

on

statistical analyses to help in providing the highest level of evidence that will help to

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 18

acquire a better evidence-based decision making on the topic. •

A limited number of studies on the subject in Low- and middle-income countries could lead to an underestimation of the burden of SSI in this specific part of the world.

10 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 11 of 18

Review status: Preliminary searches. Abbreviations

Fo

MOOSE: Meta-analysis of Observational Studies in Epidemiology.

rp

PRISMA: Preferred Reporting Items for Systematic Review and Meta-Analysis. SSI: Surgical Site Infection.

None to declare

iew

Competing interests

ev

Acknowledgments

rr

Declarations

ee

The authors declare that they have no competing interests.

on

Funding

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

This review received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Authors’ Contributions CD had the idea. CD designed and, conceived the protocol and, drafted the manuscript. MNT, JNT, RNN and JJB participated in the critical revision of the manuscript for methodology and, intellectual content. JJB is the guarantor of the review. All authors approved the final version of this manuscript. 11 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

References 1. Birnbaum BA, Wilson SR. Appendicitis at the millennium. Radiology. 2000 May;215(2):337-48. 2. Ansaloni L, Catena F, Coccolini F, Ercolani G, Gazzotti F, Pasqualini E, et al. Surgery versus conservative antibiotic treatment in acute appendicitis: a systematic review and metaanalysis of randomized controlled trials. Dig Surg. 2011;28(3):210-21. 3. Paajanen H, Gronroos JM, Rautio T, Nordstrom P, Aarnio M, Rantanen T, et al. A prospective randomized controlled multicenter trial comparing antibiotic therapy with appendectomy in the treatment of uncomplicated acute appendicitis (APPAC trial). BMC Surg. 2013 Feb 08;13:3. 4. Garcell HG, Arias AV, Sandoval CA, Garcia EG, Gamboa ME, Sado AB, et al. Incidence and Etiology of Surgical Site Infections in Appendectomies: A 3-Year Prospective Study. Oman Med J. 2017 Jan;32(1):31-5. 5. Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol. 1990 Nov;132(5):910-25. 6. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009 Jun;37(5):387-97. 7. Antal A. [Changes in epidemiology, etiology, diagnostics, and therapy of acute appendicitis]. Orv Hetil. 2009 Mar 08;150(10):443-6. 8. Minutolo V, Licciardello A, Di Stefano B, Arena M, Arena G, Antonacci V. Outcomes and cost analysis of laparoscopic versus open appendectomy for treatment of acute appendicitis: 4-years experience in a district hospital. BMC Surg. 2014 Mar 19;14:14. 9. Wei B, Qi CL, Chen TF, Zheng ZH, Huang JL, Hu BG, et al. Laparoscopic versus open appendectomy for acute appendicitis: a metaanalysis. Surg Endosc. 2011 Apr;25(4):1199-208. 10. Long KH, Bannon MP, Zietlow SP, Helgeson ER, Harmsen WS, Smith CD, et al. A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery. 2001 Apr;129(4):390-400. 11. Margenthaler JA, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson WG, et al. Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg. 2003 Jul;238(1):59-66. 12. Berry J, Jr., Malt RA. Appendicitis near its centenary. Ann Surg. 1984 Nov;200(5):567-75. 13. Leung TT, Dixon E, Gill M, Mador BD, Moulton KM, Kaplan GG, et al. Bowel obstruction following appendectomy: what is the true incidence? Ann Surg. 2009 Jul;250(1):51-3. 14. Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017 May;96(1):1-15.

iew

ev

rr

ee

rp

Fo

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 18

12 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 13 of 18

15. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003 Feb;9(2):196-203. 16. Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kubler A, Viet-Hung N, et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. 17. Foster D, Kethman W, Cai LZ, Weiser TG, Forrester JD. Surgical Site Infections after Appendectomy Performed in Low and Middle Human Development-Index Countries: A Systematic Review. Surg Infect (Larchmt). 2017 Oct 23. 18. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000 Apr 19;283(15):200812. 19. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015 Jan 01;4:1. 20. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309-32. 21. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8. 22. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012 Sep;65(9):934-9. 23. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011 Oct 18;343:d5928. 24. Miller JJ. The Inverse of the Freeman – Tukey Double Arcsine Transformation. The American Statistician. 1978 1978/11/01;32(4):138-. 25. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006 Jun;11(2):193206. 26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629-34. 27. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276-82. 28. Celestin Danwang, Mazou N Temgoua, Joël Noutakdie Tochie, Rolf Nyah Tuku Nzalie, Bigna JJ. Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol. PROSPERO 2017 [serial on the Internet]. 2017: Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017075257.

iew

ev

rr

ee

rp

Fo

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

13 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Table 1: Search strategy for PubMed from January 1st, 2000 to Decembre 30th, 2017 Search #1

Search terms

Fo

Appendectomy OR Appendicectomy OR Appendices OR “Appendix Epiploica” OR “Omental Appendix” OR Appendicitis

#2

rp

“Surgical site infection” OR “Surgical wound infection” OR “Surgical wound

ee

infections” OR “Surgical site infections” OR “Postoperative Wound Infections” OR “Postoperative Wound Infection”

#3

rr

#1 AND #2 Limits: 01/01/2000 to 30/12/2017 on humans with no language restriction

iew

ev ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 14 of 18

14 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 15 of 18 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

BMJ Open

1

PRISMA-P 2015 Checklist This checklist has been adapted for use with systematic review protocol submissions to BioMed Central journalsfrom Table 3 in Moher D et al: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews2015 4:1 An Editorial from the Editors-in-Chief of Systematic Reviews details why this checklist was adapted -Moher D, Stewart L & Shekelle P: Implementing PRISMA-P: recommendations for prospective authors. Systematic Reviews20165:15

Section/topic

#

Fo

Checklist item

ADMINISTRATIVE INFORMATION Title

rp

Information reported Page

ee

Yes

r re

No

number(s)

1

Identification

1a

Identify the report as a protocol of a systematic review

Update

1b

If the protocol is for an update of a previous systematic review, identify as such

2

If registered, provide the name of the registry (e.g., PROSPERO) and registration number in the Abstract

Contact

3a

Provide name, institutional affiliation, and e-mail address of all protocol authors; provide physical mailing address of corresponding author

1

Contributions

3b

Describe contributions of protocol authors and identify the guarantor of the review

10

4

If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; otherwise, state plan for documenting important protocol amendments

Sources

5a

Indicate sources of financial or other support for the review

10

Sponsor

5b

Provide name for the review funder and/or sponsor

10

5c

Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol

6

Describe the rationale for the review in the context of what is already known

Registration Authors

Amendments

vie

w

on

ly

3

Support

Role of sponsor/funder

10

INTRODUCTION Rationale

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

4

BMJ Open 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

Page 16 of 18

2 Information reported Page Section/topic

Objectives

#

7

METHODS

Checklist item

Yes

Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO)

Fo

rp

No

number(s) 5

Specify the study characteristics (e.g., PICO, study design, setting, time frame) and report characteristics (e.g., years considered, language, publication status) to be used as criteria for eligibility for the review

5_6

8 9

Describe all intended information sources (e.g., electronic databases, contact with study authors, trial registers, or other grey literature sources) with planned dates of coverage

6-7

10

Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated

6-7

Data management

11a

Describe the mechanism(s) that will be used to manage records and data throughout the review

7

Selection process

11b

State the process that will be used for selecting studies (e.g., two independent reviewers) through each phase of the review (i.e., screening, eligibility, and inclusion in meta-analysis)

7

Data collection process

11c

Describe planned method of extracting data from reports (e.g., piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators

7

Data items

12

List and define all variables for which data will be sought (e.g., PICO items, funding sources), any pre-planned data assumptions and simplifications

5-6

Outcomes and prioritization

13

List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale

6

Risk of bias in individual studies

Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis

7

14

15a

Describe criteria under which study data will be quantitatively synthesized

8

If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data, and methods of combining data from studies, including any planned exploration of consistency (e.g., I2, Kendall’s tau)

8-9

15b

Eligibility criteria Information sources Search strategy STUDY RECORDS

ee

r re

vie

w

on

ly

DATA

Synthesis

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 17 of 18 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

BMJ Open

3 Information reported Page Section/topic

#

Checklist item

Yes

No

number(s)

15c

Describe any proposed additional analyses (e.g., sensitivity or subgroup analyses, metaregression)

8-9

15d

If quantitative synthesis is not appropriate, describe the type of summary planned

9

Meta-bias(es)

16

Specify any planned assessment of meta-bias(es) (e.g., publication bias across studies, selective reporting within studies)

8

Confidence in cumulative evidence

17

Describe how the strength of the body of evidence will be assessed (e.g., GRADE)

Fo

rp

ee

r re

vie

w

8

on

ly

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Additional File 2. Risk of bias assessment tool for prevalence, incidence and aetiologies outcomes Risk of Bias Item

Answer: Yes (Low Risk) or No (High risk)

External Validity 1. Was the study target population a close representation of the national population in relation to relevant variables? 2. Was the sampling frame a true or close representation of the target population? 3. Was some form of random selection used to select the sample, OR, was a census undertaken? 4. Was the likelihood of non-participation bias minimal?

Fo

Internal Validity 5. Were data collected directly from the subjects (as opposed to medical records)? 6. Were acceptable case definition of condition used? 7. Was a reliable and accepted diagnosis method utilized? 8. Was the same mode of data collection used for all subjects? 9. Was the length of the shortest prevalence period for the parameter of interest appropriate? 10. Were the numerator(s) and denominator(s) for the calculation of the prevalence appropriate? 11. Summary item on the overall risk of study bias

iew

ev

rr

ee

rp

LOW RISK OF BIAS: 8 or more “yes” answers. Further research is very unlikely to change our confidence in the estimate. MODERATE RISK OF BIAS: 6 to 7 “yes” answers. Further research is likely to have an important impact on our confidence in the estimate and may change the estimate.

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 18 of 18

HIGH RISK OF BIAS: 5 or fewer “yes” answers. Further research is very likely to have an important impact on our confidence in the estimate and is likely to change the estimate.

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol

Journal:

BMJ Open

Fo

Manuscript ID Article Type:

bmjopen-2017-020101.R2 Protocol

rp

Date Submitted by the Author:

Complete List of Authors:

04-Jun-2018

Primary Subject Heading:

Keywords:

iew

Secondary Subject Heading:

Surgery

ev

rr

ee

Danwang, Celestin; Faculty of Medecine and Biomedical Sciences, Surgery and specialities Mazou, Temgoua Ngou ; Faculty of Medecine and Biomedical Sciences, Internal medicine and specialities Tochie, Joel Noutakdie; Universite de Yaounde I Faculte de Medecine et des Sciences Biomedicales, Nzalie, Rolf ; Ngong District Hospital, North Region, Cameroon Bigna, Jean Joel; Centre Pasteur of Cameroon, Department of Epidemiology and Public Health

Epidemiology, Gastroenterology and hepatology surgical site infection, appendectomy, prevalence, Incidence

ly

on For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 1 of 17

Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol Celestin Danwang1*, Mazou N. Temgoua2, Joel NoutakdieTochie1, Rolf Nyah Tuku Nzalie3, Jean Joel Bigna4, 5

1. Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon. 2. Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Fo

3. Ngong District Hospital, North Region, Cameroon.

rp

4. Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaoundé, Cameroon.

ee

5. School of Public Health, Faculty of Medicine, University of Paris Sud XI, Le KremlinBicêtre, France.

ev

rr

E-mail addresses: CD: [email protected]; MNT: [email protected]; JNT: [email protected]; RNN: [email protected]; JJB: [email protected].

iew

*Corresponding author: Dr. Celestin Danwang, MD Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon. E-mail : [email protected]. Phone number: +237696783172

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

1 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Abstract Introduction Acute appendicitis is a surgical emergency, and the most frequent etiology of acute surgical abdominal pain in developed countries. Universally, its widely approved treatment is appendectomy. Like all surgical procedures, appendectomy can be associated with many complications among which are surgical site infections (SSI). Despite the increasing number of appendectomies done around the world and the associated

Fo

morbidities related to SSI after appendectomy, there is still scarcity of data concerning the

rp

global epidemiology of SSI after appendectomy. The current review aims at providing a summary of the published data on epidemiology of SSI after appendectomy.

rr

Methods and design

ee

We will include randomized controlled trials, cohort studies, case–control and cross-sectional

ev

studies. Electronic databases including EMBASE, MEDLINE, and ISI Web of Science

iew

(Science Citation Index), will be searched for relevant abstracts of studies published between January 1, 2000, and December 30, 2017, without language restriction. The review will be

on

reported according to the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) guidelines. After screening of abstracts, study selection, data extraction,

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 17

and assessment of risk of bias, we shall assess the studies individually for clinical and statistical heterogeneity. Appropriate meta-analytic techniques will then be used to pool studies judged to be clinically homogenous. Visual inspection of Funnel-plots, and Egger’s test will be used to detect publication bias. Results will be presented by country and continent.

2 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 3 of 17

Ethics and dissemination Since primary data are not collected in this study, ethical approval is not required. This review is expected to provide relevant data to help in quantifying the global burden of SSI after appendectomy. The final report will be published in a peer-reviewed journal. Systematic review registration: International Prospective Register for Systematic Reviews (PROSPERO) number: CRD42017075257.

Fo

Keywords: surgical site infections; appendectomy; prevalence, incidence.

rp

Strengths and limitations of the study •

ee

To the best of our knowledge, this will be the first global systematic review summarizing contemporary data on the occurrence of SSI after appendectomy. This review will be conducted with strong and, robust methodological processes and,

ev



rr

statistical analyses to help in providing the highest level of evidence that will help to

iew

acquire a better evidence-based decision making on this topic. •

A limited number of studies on the subject in low- and middle-income countries could lead to an underestimation of the burden of SSI in this specific part of the world.

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

3 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Introduction Defined as an acute inflammation of the appendix, acute appendicitis is the most frequent etiology of acute surgical abdominal pain in developed countries (1). Its currently approved standard of treatment is appendectomy (2, 3). In the USA, the annual number of people

Fo

undergoing appendectomy in acute care hospital is estimated at 300 000 (4-6).

rp

Appendectomy can be performed through a laparoscopic or an open surgery technique, with laparoscopy being the most recommended method (7-10). This is because, the former is

ee

associated with reduced postoperative pain, a short length of hospital stay with a subsequent earlier return to day-to-day activities, reduced postoperative ileus, and better cosmetic results

rr

(7-10). Within the last five decades, the mortality associated with acute appendicitis has

ev

drastically dropped from 26% to less than 1% (11, 12).

iew

Like all surgical procedures, appendectomy can be associated with several postoperative complications like persistent ileus, cecal fistula, pelvic or abdominal abscess, and surgical site

on

infections (SSI) (13). SSI are associated with a prolonged postoperative morbidity, a substantial additional healthcare cost, making this complication a concern for all surgical

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 17

teams (14, 15). Some studies done in Brazil, Sweden, China and the USA report SSI prevalence rates of 7.2%, 5.9%, 6.2% and 2.9% respectively after appendectomy (16). Moreover, a recent systematic review on surgical site infections after appendectomy performed in low and middle human development-index countries (LMHDICs) (17) found a high rate of SSI in LMHDICs compared to data of isolated studies done in high Human Development-Index Countries (HHDICs). The aforementioned systematic review differs from the review we plan to do by the fact that, our systematic review will integrate data from 4 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 5 of 17

developed and developing countries, hence, this will help provide a global estimation of the burden posed by SSI after appendectomy. In addition, our systematic review will be associated with meta-analysis. Faced with this gap in the contemporary literature, it is evident that there is still scarcity of data regarding the global epidemiology of SSI after appendectomy, despite the increasing number of appendectomies done in the world. The current systematic review and metaanalysis aim at summarizing the available data concerning prevalence and incidence of SSI

Fo

after appendectomy.

Review questions

rr

ee

rp 1. What is the global prevalence of surgical site infection after appendectomy?

ev

2. What is the global incidence of surgical site infection after appendectomy?

Objectives

iew

This systematic review and meta-analysis aims to:

on

1. Determine the global prevalence of SSI after appendectomy;

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

2. Determine the global incidence of SSI after appendectomy.

Methods and design This systematic review and meta-analysis will be reported in conformity with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines (18). For the present protocol, the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA-P) for Protocol was used for the reporting (19). An additional file shows the PRISMA-P for protocol checklist [see Additional File 1]. 5 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Criteria for considering studies for the review Types of participants We will include all participants regardless of their country, age and ethnicity. Types of studies We will include randomized controlled trials, cohort studies, case–control and cross-sectional studies. Only studies reporting the used of CDC (Center for Disease Control) terminology

Fo

and, diagnostic criteria for SSI will be considered (20, 21).

rp

Letters to the editor, narrative reviews, commentaries, perspectives and editorials will be excluded. Types of outcomes

rr

ee

We will consider studies reporting the following outcomes with enough data to compute these estimates: •

Prevalence of SSI after appendectomy;



Incidence of SSI after appendectomy.

iew

ev on

Studies, in which relevant data on SSI after appendectomy is impossible to extract even after contacting the corresponding author will be excluded. Other criteria

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 17

 All published data between January 1, 2000 and December 30, 2017 will be considered.  No language restriction will be applied.  For duplicates of studies published in more than one report, the one reporting the largest sample size will be considered.  Studies with inaccessible full text either online or from the corresponding author will be excluded. 6 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 7 of 17

Search strategy for identifying relevant studies The search strategy will be conducted in two stages: Bibliographic database searches Relevant articles published on SSI after appendectomy will be identified by searching Excerpta Medica Database (EMBASE), MEDLINE through PubMed, and ISI Web of Science (Science Citation Index), between January 1, 2000 and December 30, 2017, without any

Fo

language restriction. Text words, and medical subject heading terms related to SSI, and appendicitis will be used (Table 1). When necessary, contact with authors for more

rp

information will be made.

ee

Searching for other sources

rr

We will scan the references of all relevant articles for additional data sources missed during our search, and their full-texts will be retrieved. References of pertinent reviews will also be scanned.

iew

ev

Selection of studies for inclusion in the review

Two reviewers (CD and MNT) will independently evaluate the studies obtained from the

on

searches, using an assessment form to ensure that the selection criteria are reliably applied.

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

These reviewers will screen the titles, and abstracts of papers obtained, after which the full texts of potentially eligible papers will be retrieved by at least one reviewer. The two reviewers will independently review the full text of each potentially eligible study, compare their results, and resolve any discrepancy by the arbitration of a third reviewer (JNT). Assessment of methodological quality and reporting of data

7 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Methodological quality, and risk of bias of included studies will be assessed using the tool of bias assessment for Prevalence Studies developed by Hoy et al (22), and the Cochrane’s bias assessment tool for randomized studies (23). Data extraction and management All references identified after implementation of the searched strategy will be imported inside the Endnote software. All records obtained from various databases will be combined in a

Fo

single Endnote library, and the duplicates will be noted, and removed. A data extraction form will thereafter be used to collect information on the last name of the first author, year of

rp

publication, continent, country, study design, study area (rural versus urban), age groups

ee

(children or adults), sample size, mean or median age, gender, specific characteristics of the study population, high-risk patients for SSI (patients with diabetes mellitus, HIV/AIDS),

rr

clinical type of appendicitis (catarrhal, perforated, suppurated, gangrenous), medical

ev

interventions before appendectomy (antibiotherapy, analgesics) health care facility (primary

iew

or other center), the surgical method (open surgery or laparoscopy), prevalence, and incidence of SSI after appendectomy in the study population. For multinational studies, the prevalence, and incidence will be reported for the individual countries. Where it is impossible to

on

disaggregate data of multinational studies by country, the study will be presented as one, and the countries in which the study was done will be reported.

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 17

Data synthesis and analysis After data collection, a meta-analysis will be conducted. Unadjusted prevalence, and incidence, and standard errors for the study-specific estimates will be recalculated based on the information of crude numerators, and denominators provided by individual studies. To keep the effect of studies with extremely small or extremely large prevalence estimates on the overall estimate to a minimum, the variance of the study-specific prevalence/incidence will be 8 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 9 of 17

stabilized with the Freeman-Tukey double arc-sine transformation (24), before poling the data using a random effects meta-analysis model. Heterogeneity will be assessed using the χ2 test on Cochrane’s Q statistic, and quantified by calculating I2 (25). Values of 25%, 50% and, 75% for I2 will respectively represent low, medium and, high heterogeneity. We will assess the presence of publication bias using funnel plots inspection and, Egger’s test (26). Where substantial heterogeneity will be detected, meta-regression, and subgroup analyses will be performed to investigate the possible sources of heterogeneity using the aforementioned

Fo

variables, and the study quality. In case of substantial clinical heterogeneity, a narrative

rp

summary of our findings will be done. The inter-rater agreement for study inclusion between investigators will be assessed using Cohen’s κ coefficient (27). Data analyses will be done

ee

using the ‘meta’ package of the statistical software R (version 3.2.2 [2014-08-14], The R Foundation for statistical computing, Vienna, Austria). This systematic review protocol is

rr

registered under the review number: CRD42017070480 in the International Prospective

ev

Register of Systematic Reviews (PROSPERO) (28). Presentation and reporting of results

iew

The study selection process will be summarized using a flow diagram. Quantitative data will

on

be presented in tables of individual studies, and in summary tables, and forest plots where appropriate. The quality scores, and risk of bias for each eligible study will be reported

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

accordingly. This may be tabulated, and accompanied by narrative summaries. Patient and Public Involvement

In this study, data will not be collected directly from patients, but in published studies available in main databases.

9 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

Potential amendments Any amendment in the review process will be reported for transparency.

Conclusion SSI after appendectomy is one of the complications of the surgical treatment of appendicitis. This systematic review aims at providing high quality evidence on the epidemiology of SSI after appendectomy. We hope this review will help to sensitize surgeons to implement

Fo

effective strategies to prevent SSI in order to scale-down the burden SSI after appendectomy.

iew

ev

rr

ee

rp Review status:

ly

Preliminary searches.

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 17

Abbreviations

PRISMA: Preferred Reporting Items for Systematic Review and Meta-Analysis. SSI: Surgical Site Infection.

10 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 11 of 17

Declarations Acknowledgments None to declare Competing interests The authors declare that they have no competing interests. Funding

Fo

This review received no specific grant from any funding agency in the public, commercial or

rp

not-for-profit sectors.

Authors’ Contributions

ee

CD had the idea. CD designed and, conceived the protocol and, drafted the manuscript. MNT,

rr

JNT, RNN and JJB participated in the critical revision of the manuscript for methodology

ev

and, intellectual content. CD and JJB are the guarantor of the review. All authors approved the final version of this manuscript.

iew

References

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

1. Birnbaum BA, Wilson SR. Appendicitis at the millennium. Radiology 2000 ;215:33748. 2. Ansaloni L, Catena F, Coccolini F, Ercolani G, Gazzotti F, Pasqualini E, et al. Surgery versus conservative antibiotic treatment in acute appendicitis: a systematic review and metaanalysis of randomized controlled trials. Dig Surg 2011;28:210-21. 3. Paajanen H, Gronroos JM, Rautio T, Nordstrom P, Aarnio M, Rantanen T, et al. A prospective randomized controlled multicenter trial comparing antibiotic therapy with appendectomy in the treatment of uncomplicated acute appendicitis (APPAC trial). BMC Surg 2013;13:3. 4. Garcell HG, Arias AV, Sandoval CA, Garcia EG, Gamboa ME, Sado AB, et al. Incidence and Etiology of Surgical Site Infections in Appendectomies: A 3-Year Prospective Study. Oman Med J 2017;32:31-5. 11 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

5. Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol 1990;132:910-25. 6. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009 ;37:387-97. 7. Antal A. [Changes in epidemiology, etiology, diagnostics, and therapy of acute appendicitis]. Orv Hetil 2009;150:443-6. 8. Minutolo V, Licciardello A, Di Stefano B, Arena M, Arena G, Antonacci V. Outcomes and cost analysis of laparoscopic versus open appendectomy for treatment of acute appendicitis: 4-years experience in a district hospital. BMC Surg 2014;14:14. 9. Wei B, Qi CL, Chen TF, Zheng ZH, Huang JL, Hu BG, et al. Laparoscopic versus open appendectomy for acute appendicitis: a metaanalysis. Surg Endosc 2011;25:1199-208. 10. Long KH, Bannon MP, Zietlow SP, Helgeson ER, Harmsen WS, Smith CD, et al. A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery 2001;129:390-400. 11. Margenthaler JA, Longo WE, Virgo KS, Johnson FE, Oprian CA, Henderson WG, et al. Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg 2003;238:59-66. 12. Berry J, Jr., Malt RA. Appendicitis near its centenary. Ann Surg 1984 ;200:567-75. 13. Leung TT, Dixon E, Gill M, Mador BD, Moulton KM, Kaplan GG, et al. Bowel obstruction following appendectomy: what is the true incidence? Ann Surg 2009 ;250:51-3. 14. Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect 2017;96:1-15. 15. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003;9:196-203. 16. Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kubler A, Viet-Hung N, et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013;34:597-604. 17. Foster D, Kethman W, Cai LZ, Weiser TG, Forrester JD. Surgical Site Infections after Appendectomy Performed in Low and Middle Human Development-Index Countries: A Systematic Review. Surg Infect (Larchmt) 2017. 18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. 19. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1. 20. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. 21. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8. 22. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012 ;65:934-9.

iew

ev

rr

ee

rp

Fo

ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 17

12 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 13 of 17

23. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. 24. Miller JJ. The Inverse of the Freeman – Tukey Double Arcsine Transformation. The American Statistician 1978;32:138-. 25. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods2006;11:193-206. 26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. 27. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276-82. 28. Celestin Danwang, Mazou N Temgoua, Joël Noutakdie Tochie, Rolf Nyah Tuku Nzalie, Bigna JJ. Global prevalence and incidence of surgical site infections after appendectomy: a systematic review and meta-analysis protocol. PROSPERO 2017 [serial on the Internet]. 2017: Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017075257.

iew

ev

rr

ee

rp

Fo

Table 1: Search strategy for PubMed from January 1st, 2000 to December 30th, 2017

on

Search

Search terms

#1

Appendectomy OR Appendicectomy OR Appendices OR “Appendix

ly

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

BMJ Open

Epiploica” OR “Omental Appendix” OR Appendicitis #2

“Surgical site infection” OR “Surgical wound infection” OR “Surgical wound infections” OR “Surgical site infections” OR “Operative site infections” OR “Postoperative Wound Infections” OR “Postoperative Wound Infection”

#3

#1 AND #2 Limits: 01/01/2000 to 30/12/2017 on humans with no language

13 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

BMJ Open

restriction

iew

ev

rr

ee

rp

Fo ly

on

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 14 of 17

14 For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 15 of 17 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

BMJ Open

1

PRISMA-P 2015 Checklist This checklist has been adapted for use with systematic review protocol submissions to BioMed Central journalsfrom Table 3 in Moher D et al: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews2015 4:1 An Editorial from the Editors-in-Chief of Systematic Reviews details why this checklist was adapted -Moher D, Stewart L & Shekelle P: Implementing PRISMA-P: recommendations for prospective authors. Systematic Reviews20165:15

Section/topic

#

Fo

Checklist item

ADMINISTRATIVE INFORMATION Title

rp

Information reported Page

ee

Yes

r re

No

number(s)

1

Identification

1a

Identify the report as a protocol of a systematic review

Update

1b

If the protocol is for an update of a previous systematic review, identify as such

2

If registered, provide the name of the registry (e.g., PROSPERO) and registration number in the Abstract

Contact

3a

Provide name, institutional affiliation, and e-mail address of all protocol authors; provide physical mailing address of corresponding author

1

Contributions

3b

Describe contributions of protocol authors and identify the guarantor of the review

10

4

If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; otherwise, state plan for documenting important protocol amendments

Sources

5a

Indicate sources of financial or other support for the review

10

Sponsor

5b

Provide name for the review funder and/or sponsor

10

5c

Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol

6

Describe the rationale for the review in the context of what is already known

Registration Authors

Amendments

vie

w

on

ly

3

Support

Role of sponsor/funder

10

INTRODUCTION Rationale

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

4

BMJ Open 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

Page 16 of 17

2 Information reported Page Section/topic

Objectives

#

7

METHODS

Checklist item

Yes

Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO)

Fo

rp

No

number(s) 5

Specify the study characteristics (e.g., PICO, study design, setting, time frame) and report characteristics (e.g., years considered, language, publication status) to be used as criteria for eligibility for the review

5_6

8 9

Describe all intended information sources (e.g., electronic databases, contact with study authors, trial registers, or other grey literature sources) with planned dates of coverage

6-7

10

Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated

6-7

Data management

11a

Describe the mechanism(s) that will be used to manage records and data throughout the review

7

Selection process

11b

State the process that will be used for selecting studies (e.g., two independent reviewers) through each phase of the review (i.e., screening, eligibility, and inclusion in meta-analysis)

7

Data collection process

11c

Describe planned method of extracting data from reports (e.g., piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators

7

Data items

12

List and define all variables for which data will be sought (e.g., PICO items, funding sources), any pre-planned data assumptions and simplifications

5-6

Outcomes and prioritization

13

List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale

6

Risk of bias in individual studies

Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis

7

14

15a

Describe criteria under which study data will be quantitatively synthesized

8

If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data, and methods of combining data from studies, including any planned exploration of consistency (e.g., I2, Kendall’s tau)

8-9

15b

Eligibility criteria Information sources Search strategy STUDY RECORDS

ee

r re

vie

w

on

ly

DATA

Synthesis

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml

Page 17 of 17 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

BMJ Open

3 Information reported Page Section/topic

#

Checklist item

Yes

No

number(s)

15c

Describe any proposed additional analyses (e.g., sensitivity or subgroup analyses, metaregression)

8-9

15d

If quantitative synthesis is not appropriate, describe the type of summary planned

9

Meta-bias(es)

16

Specify any planned assessment of meta-bias(es) (e.g., publication bias across studies, selective reporting within studies)

8

Confidence in cumulative evidence

17

Describe how the strength of the body of evidence will be assessed (e.g., GRADE)

Fo

rp

ee

r re

vie

w

8

on

ly

For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml